threo-N-ethylritalinol hydrochloride

ID: ALA553859

Chembl Id: CHEMBL553859

PubChem CID: 16720957

Max Phase: Preclinical

Molecular Formula: C15H24ClNO

Molecular Weight: 233.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Threo-N-Ethylritalinol HCl | CHEMBL553859|Threo-N-Ethylritalinol HCl

Canonical SMILES:  CCN1CCCC[C@@H]1[C@H](CO)c1ccccc1.Cl

Standard InChI:  InChI=1S/C15H23NO.ClH/c1-2-16-11-7-6-10-15(16)14(12-17)13-8-4-3-5-9-13;/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3;1H/t14-,15-;/m1./s1

Standard InChI Key:  SXBGSGKJIAMWDZ-CTHHTMFSSA-N

Associated Targets(non-human)

Slc6a3 Dopamine transporter (6071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a2 Norepinephrine transporter (2222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a4 Serotonin transporter (6087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a4 Monoamine transporters; serotonin & dopamine (1148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 233.35Molecular Weight (Monoisotopic): 233.1780AlogP: 2.64#Rotatable Bonds: 4
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.68CX LogP: 2.44CX LogD: 0.18
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: 0.14

References

1. Kim DI, Deutsch HM, Ye X, Schweri MM..  (2007)  Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.,  50  (11): [PMID:17489581] [10.1021/jm061354p]

Source